| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |